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Summary: A radioimmunoassay for the determination of pig pancreatic kallikrein was developed. The chloramine-T 
method was employed for the labelling of the antigen with 1 2 5 I . The assay allows the determination of kallikrein in 
concentrations as low as 0.4 /ig/1. Pig urinary and pig submandibular kallikreins are indistinguishable from pig 
pancreatic kallikrein by the assay. No cross reactivity was observed for bovine trypsin and chymotrypsin, 
porcine trypsin and kallikreins of guinea pig submandibular glands and guinea pig coagulation glands. Because of 
the high specificity of the assay, which is not attainable with conventional assays based on the enzymatic activity, 
the radioimmunoassay is highly suited for investigations into the physiological role and the pharmacological 
mechanism of action of pig glandular kallikreins. 
E n t w i c k l u n g eines Radioimmunoassays fur Kallikrein aus Schweinepankreas 
Zusammenfassung: Für die Bestimmung von Schweinepankreaskallikrein wurde ein Radioimmunoassay entwickelt. 
Die Markierung des Antigens mit 1 2 5 J erfolgte nach der Chloramin-T-Methode. Der Radioimmunoassay gestattet die 
Bestimmung von Kallikrein in Konzentrationen bis herab zu 0,4 /ig/1. Kallikreine aus Schweineharn und Schweine -
submandibularisdrüsen sind im Radioimmunoassay nicht von Schweinepankreaskallikrein zu unterscheiden. Keiner-
lei Kreuzreaktion wurde für Trypsin (Rind, Schwein), Chymotrypsin (Rind) und Kallikreine aus Submandibularis-
drüsen und Koagulationsdrüsen von Meerschweinchen gefunden. Auf Grund der hohen Spezifität der Bestimmungs-
methode, die mit konventionellen, auf der enzymatischen Aktivität beruhenden Methoden nicht erreicht wird, ist 
der Radioimmunoassay bestens geeignet für Untersuchungen über die physiologische Funktion und den pharmako-
logischen Wirkungsmechanismus von Schweinepankreaskallikrein. 
Introduction 
The determination of kallikrein is usually achieved by 
measuring the rate of hydrolysis either of synthetic 
substrates or of the natural substrate kininogen (1-3). 
These assays are not specific for kallikrein, because they 
also detect other proteases. For studies on the physiolog 
ical function and the pharmacological mechanism of 
action of kallikrein, which include the measurement of 
the enzyme in tissues and body fluids, a more specific 
assay is required. This requirement is met by the radio-
immunoassay technique, which is based on the compe-
titive inhibition of the binding of labelled antigen to its 
specific antibody by the unknown or by the unlabelled 
antigen used as a standard. 
By employing this method an assay was developed, with 
a sensitivity (lower detection limit 40-300 pg) as high 
as that of the most sensitive enzymatic assays (1). 
J. Clin. Chem. Clin. Biochem. / Vol. 16,1978 / No. 7 
The radioimmunoassay is specific for pig kallikreins of 
pancreas, urine and submandibular gland. All other 
proteinases investigated so far do not interfere in the 
assay. 
Materials and Methods 
Pig pancreatic kallikrein used for radioiodination and as a 
standard in the radioimmunoassay was a highly purified 
neuraminidase-treated preparation (3) kindly provided by 
Dr. F . F i e d l e r , Munich. Pig trypsin, Merck, Cat. No. 8350; 
cristalline bovine trypsin, Novo Industri; guinea pig coagula-
tion gland kallikrein and guinea pig submandibular kallikrein 
were gifts from Dr. C. M o r i w a k i , Tokyo and Dr. M . L e m o n , 
Bristol. Pig urinary kallikrein and pig submandibular kalli-
krein preparations were isolated as described (4,5). Rabbit 
anti-kallikrein serum was a gift of Bayer A G , Wuppertal; 
donkey anti-rabbit IgG serum was purchased from Wellcome 
Company, Cat, No. R D 17. 
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B u f f e r s 
Buffer A: 0.015 mol/1 NaH 2 P0 4 ,0 .15 mol/i NaCl, 200 mg 
Merthiolate, 2 g/1 bovine serum albumin, 0.01 mol/1 E D T A , 
pH 7.4; 
Buffer B: 0.015 mol/1 NaH 2 P0 4 ,0 .15 mol/1 NaCl, 200 mg/1 
Merthiolate, 40 g/1 bovine serum albumin, pH 7.4; 
Buffer C: 0.015 mol/1 NaH 2 P0 4 ,0 .15 mol/1 NaCl, pH 7.4. 
Radioiodination 
The modification of the chloramine T method of Greenwood 
& H u n t e r (6) described by E r h a r d t et al. (7) was used for the 
radioiodination of kallikrein. All reagents were dissolved in 
buffer C. The reaction was started by adding 10 M1 (18.5 MBq = 
0.5 mCi) N a 1 2 5 I and 10 M1 (30 jig) chloramine-T to 5 ßl (2.5 /ig) 
kallikrein solution. After 5-10 s of mixing the reaction was 
stopped by 20 ß\ (60 Mg) sodium metabisulfite. The reaction 
mixture was then transferred to a Sephadex G-75 column 
1.2 X 14 cm, the reaction vial was washed once with 50 p \ of a 
10 g/1 potassium iodide solution. The column was eluted with 
buffer C (40 ml/h), and 0.8 ml fractions were collected into 
disposable polypropylene tubes containing 50 n i of buffer B. 
The radioactivity of the fractions was determined and the 4-6 
fractions with the highest radioactivity of the peak correspond-
ing to the elution volume of kallikrein were pooled and diluted 
with buffer A to a concentration of 250 000 counts/min • ml 
for use in the radioimmunoassay. 
Radioimmunoassay conditions 
Dilutions of kallikrein standard samples, unknowns, anti-rabbit 
IgG serum and 1 2 5I-kallikrein were prepared with buffer A. 
70 mg/1 of rabbit IgG were added to the 1 2 5I-kallikrein solution. 
Anti-kallikrein serum was diluted with buffer B so as to give a 
binding fraction of 0.50 1 2 SI-kallikrein under the conditions 
employed in the radioimmunoassay. 
The incubation mixtures were set up in disposable polypropylene 
tubes following the scheme given in table 1. After an incubation 
period of 24-48 h, 0.1 ml of the solution of anti-rabbit IgG 
serum (diluted according the recommendation of the manu-
facturer) was added. After another 2-3 h, 0.5 ml buffer A were 
added. After 10 min centrifugation at 6000 g the supernatant was 
removed by aspiration and the radioactivities of the precipitates 
were measured in a gamma counter. All calibration samples were 
set up in quadruplicate. 
Standard curves were obtained by plotting the fraction of bound 
radioactivity, ^ ^ (B: counts bound, B 0 : counts read for zero 
B 0 - N 
dose, N: non specifically bound counts), against ng kallikrein in a 
linear-log mode. The assays were evaluated by means of a com-
puter employing the spline approximation method (8-10). 
Specificity 
The immunological reactivity of anti-kallikrein serum with other 
proteases was checked by employing, per incubation tube, 10 ng 
— 100 Mg of bovine trypsin, bovine chymotrypsin, or porcine 
trypsin; 0.1 ng-10 Mg of kallikreins from guinea pig submandi-
bular and coagulation glands; and approximately 0.1-10 ng of 
pig submandibular and pig urinary kallikrein. 
Tab. 1. Preparation of radioimmunoassay incubation mixtures 
The amounts of the solutions pipetted into polypropylene 
disposable tubes are shown in the table. 
Buffer A Buffer B Sample1) Anti- 1 2 5I-kalli-
kallikrein krein 
serum 
Ml Ml Ml Ml Ml 
N 200 100 - - 100 
Bo 200 — — 100 100 
Samples 100 - 100 100 100 
*) Standard or unknowns 
Results 
Properties o f Ì 2 S I - l a b e l l e d kallikrein 
The chloramine-T method (6,7) was employed for the 
iodination of kallikrein. The reaction mixture was imme-
diately subjected to gel filtration which effectively 
separated the labelled kallikrein from unreacted Na 1 2 5 I 
(fig. 1). In one experiment the immunological reactivity 
of the fractions of the 125I-kallikrein peak was checked 
by setting up titration curves for each fraction. Except 
for the first fraction of the peak, with a maximum 
binding of 0.28, no significant differences in the maxi-
mum binding (0.82 for all other fractions) and in the 
slopes of the curves were observed. Therefore, for use 
in the radioimmunoassay, usually the 4-6 fractions 
representing the maximum of the 125I4callikrein peak 
(fractions 11-15 in fig. 1) were pooled. The specific 
radioactivity of the 125I-kallikrein preparations, cal-
culated from the radioactivity eluted in the kallikrein 
peak, was 1.11-4.8 MBq//ig (30-130 ßCi/pg), the mean 
value ± standard deviation of 21 iodinations was 2.85 ± 
0.93 MBq/jUg (77 ± 25 /iCi/jttg). 
The 125I-labelled kallikrein was used in the radioimmuno-
assay for up to five weeks. During this time the fraction 
of radioactivity precipitable with an equal volume of 
100 g/1 trichloroacetic acid decreases from 0.98 to about 
0.80. 
Figure 2 shows a typical titration curve. The maximum 
binding of 21 125I-kallikrein preparations varied between 
0.38 and 0.86 (0.68 ± 0.14, mean ± S.D.). Only prep-
arations with a maximum binding higher than 0.50 (20 
out of 21 preparations) were used in the radioimmuno-
assay. 
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 
Fraction number 
Fig. 1. Separation of 1 2 5 I labelled pig pancreatic kallikrein 
(fractions 9-19) from unreacted Na 1 2 5 I on a Sephadex 
G 75 column (1.2 X 14 cm). 
Fraction volume: 0.8 ml, elution buffer: buffer C. The 
radioactivity of the fractions was measured with geometry 
adjusted to low counting efficiency. In this experiment 
fractions 11-15 were pooled for use in the radioimmuno-
assay. 
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Fig. 3. Time and temperature-dependence of the binding of 
1 2 SI-kallikrein to antibody. 
Incubation mixtures correspond to BQ and N in Table 1. 
The samples were held at 8 °C • — • , 25 °C • — • and 
37 °C o—o. The incubation was stopped by freezing the 
samples at - 78 °C. The frozen samples were stored at 
- 21 °C. All samples were thawed simultaneously at 
30 °C for 3 min and the second antibody was added to 
precipitate the bound 1 2 5I-kallikrein. 
Precision 
Both intraassay and interassay precision are dependent 
on the concentration of kallikrein in the sample. In the 
range of 0.3 to 5 ng per incubation mixture the coeffi-
cient of variation for quadruplicates is generally 6-10%. 
For the interassay precision the coefficient of variation 
for the same concentration range calculated from 6 
consecutive assays was 6-15%. 
Sensitivity 
The lower detection limit is generally between 0.4 and 
3.0 /ig/1 sample volume, depending on the quality of 
the labelled kallikrein and the incubation conditions 
(fig. 4). 
1:160000 1:320000 1:640000 1:1280000 1:25600001:5120000 1:10240000 
Antiserum dilution 
Fig. 2. Antiserum titration curve. 
The tubes, containing 200 M1 buffer B, 100 ß\ anti-kalli-
krein serum dilution and 100 n \ 1 2 5I-kallikrein 
(28000 counts/min) were held at room temperature for 
2 days. Bound 1 2 5I-kallikrein was precipitated by the 
addition of 100 n \ of second antibody dilution. The anti-
serum dilutions given in the figure are the final dilutions 
in the incubation mixture. 
K i n e t i c s of t h e binding of i 2 S I ' k a l l i k r e i n t o t h e antibody 
In order to find the optimal incubation conditions for 
the routine radioimmunoassay the kinetics of the 
binding of 125I-kallikrein to the antibody was studied at 
8,22 and 37° C. Figure 3 summarizes the results. The 
lowest binding rate is observed at 8°C and, as indicated 
by the shape of the curve, the endpoint is not yet reached 
after 120 h. Both at 25 and 37°C equilibrium is reached 
between 48 and 72 h; maximum binding at 37°C is 
significantly lower than at 25°C. 
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Fig. 4. Influence of preincubation on standard curves. 
Reagents were used as summarized in Table 1. Incubation 
conditions: 
A: preincubation of tracer and anti-kallikrein serum for 
42 h followed by 24 h after addition of standard 
( A — A ) ; 
B: incubation of standard, anti-kallikrein serum and 
tracer for 42 h (•—•); 
C: preincubation of standard and anti-kallikrein serum 
for 42 h followed by 24 h after addition of tracer. 
0.90 intercept defined as lower detection 
limit. 
Specificity 
In order to test the specificity of the antiserum several 
serine proteases were evaluated with respect to their 
capacity to inhibit competitively the binding of l 2 5 I -
kallikrein. Absolutely no cross reactivity was observed 
for bovine trypsin and chymotrypsin, porcine trypsin 
and guinea pig coagulation gland and submandibular 
gland kallikrein applied in the concentrations described 
above. The kallikreins of pig urine and pig submandibular 
glands showed immunological reactivities (nearly) 
identical to pig pancreatic kallikrein (fig. 5). 
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Fig. 5. Cross reactivity of pig urinary kallikrein (o—o) and pig 
submandibular kallikrein (•—•) in the radioimmuno-
assay for pig pancreatic kallikrein (•—•). 
The exact concentration of urinary and submandibular 
kallikreins was not known. 
Discussion 
The chloramine-T method (6,7), widely used for the 
iodination of proteins, was successfully applied to 
produce 125ï-labelled pig pancreatic kallikrein. The 
iodinated protein is stable, immunologically active and 
of sufficiently high specific radioactivity for setting up 
a sensitive radioimmunoassay. The stability of the 
iodinated kallikrein was checked by determining the 
amount of radioactivity bound to high molecular weight 
protein: in four week old preparations a fraction of 0.8 
of the radioactivity was still precipitable by trichloro-
acetic acid. 
The immunological reactivity of kallikrein is not 
seriously effected by the labelling procedure. If a 
constant amount of freshly prepared 125I4callikrein is 
incubated with a series of antiserum dilutions (fig. 2), 
the maximum binding is usually higher than 0.80; it 
decreases for older preparations owing to the release of 
low molecular weight radioactive substances, which are 
not bound by the antibody. If these radioactive low 
molecular weight fragments are removed by gel filtration 
almost the same maximum binding is observed as for 
fresh preparations. Nevertheless, the 125I-kallikrein is 
not generally used for longer than five weeks, because 
the sensitivity of the assay decreases with the age of the 
preparation. 
The results of the kinetic studies (fig. 3) of the binding 
of 125Ucallikrein to the antibody at 8,25 and 37°C 
show that incubation at room temperature (20-25°C) 
is preferable for the radioimmunoassay. At low temper-
atures the reaction is relatively slow, whereas at higher 
temperatures the equilibrium is more in favour of 
dissociation. We routinely incubate the samples at room 
temperature for 36-48 h. Under these conditions the 
binding is close to equilibrium. In earlier experiments we 
had observed a significant decrease of binding for in-
cubation periods longer than 72 h at all three temper-
atures investigated (11). We interpreted this effect as a 
loss of immunological reactivity of the 125I-kallikrein 
and/or the antibody. Since, in our recent experiments, 
we used the same antiserum but a different 1 2 5I-kalli-
krein preparation and did not observe a significant 
decrease of binding, it seems likely that properties of 
the 125I-kallikrein and not of the antiserum were respon-
sible for this effect. 
The sensitivity of radioimmunoassays can be increased 
by preincubating unlabelled antigen with the antibody 
before the labelled antigen is added. This technique 
can also be employed successfully in the kallikrein 
radioimmunoassay. As figure 4 demonstrates, prein-
cubation for 42 hours before addition of the labelled 
antigen causes a shift of the standard curve toward 
lower kallikrein concentrations and an increase of the 
slope. The lower detection limit is reduced to one half 
in figure 4 (with the 0.90 intercept defined as the lower 
detection limit). In other experiments it was reduced 
occasionally even to one fourth. For most of our 
investigations this increased sensitivity is not required 
and, because the total incubation time would be three 
instead of two days, we do not apply the preincubation 
method routinely. 
The specificity of the test was examined by employing 
a variety of serine proteases in the radioimmunoassay. 
Because of the structural homology of pig pancreatic 
kallikrein with other serine proteases (3) immunological 
cross reactivity seems possible. However, it turned out 
that only the kallikreins of pig submandibular gland and 
pig urine show cross reactivity. No cross reactivity at all 
was observed for bovine trypsin and chymotrypsin, 
porcine trypsin and kallikreins of guinea pig submand-
ibular glands and guinea pig coagulation glands. The 
(nearly) identical slope of the dose response curves 
(fig. 5) indicates a high similarity if not identity of the 
three porcine kallikreins in their immunological pro-
perties. With the antiserum we use it is impossible to 
discriminate between the three enzymes by means of the 
radioimmunoassay. This finding is in agreement with 
results found by immunodiffusion and immunoelectro-
phoretic studies (12). Identical precipitation patterns 
were obtained by the authors using the double diffusion 
technique of O u c h t e r l o n y , when the three kallikreins 
were allowed to diffuse against purified rabbit IgG 
directed against any one of the kallikreins. In the immuno-
electrophoretic studies different electrophoretic mobilities 
of the various kallikreins were observed but immunolog-
ical identity was indicated by the form, location and 
confluence of the precipitin lines. 
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Immunological similarity has also been demonstrated by 
Geiger & Mann ( 13) and Ole-Moiyoi et al. ( 14) for human 
saliva, pancreatic and urinary kallikreins using antibodies 
directed against human urinary kallikrein and human 
pancreatic extract, respectively. 
The radioimmunoassay for pig pancreatic kallikrein was 
developed with the aim of applying it in studies on the 
pharmacological effects and the physiological role of this 
enzyme. Both high specificity and sensitivity are pre-
requisites for an assay to be used in such studies, since 
body fluids and tissues have to be examined which might 
also contain other proteases. The radioimmunoassay 
presented here is specific for pig glandular kallikreins. 
However, a discrimination of the different pig glandular 
kallikreins is not possible. This may cause difficulties in 
some physiological studies where such a discrimination 
might be desirable. It seems to us to be impossible to 
solve this problem, as long as the differences between the 
glandular kallikreins are not fully understood (12). For 
studies on the effects of pig pancreatic kallikrein in ani-
mals other than the pig, we expect from our investigations 
that the problem of cross reacting substances will not 
arise. Some pharmacological studies on the effects of 
kallikrein on dogs after parenteral application are already 
published (11). 
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